CellProthera is a company founded in 2008 in Mulhouse (France) to research, develop and commercialize innovative therapeutic solutions for the regeneration of organs damaged by disease or trauma but also to develop the means to industrialize cell manufacturing in a cost effective manner.

CellProthera therapeutic focus is on the commercial development of an approach allowing the regeneration of myocardial tissue to treat acute myocardial infarction and prevent secondary congestive heart failure.
CellProthera innovative solution has been successfully tested in a proof of concept clinical study, started in 2002 by its president, Pr. Philippe Henon, using autologous peripheral blood CD34+ stem cells directly reinjected into the cardiac lesion of patients after acute myocardial infarct. The clinical outcomes indicated an excellent safety profile associated with a long term outstanding recovery of their cardiac function, which allowed the study patients to return to a normal life.

1 George Street, Lobby B, #10-01, The Great Room, Singapore 049145

godaddy vs fatcow